| Model Number |
MF-410525 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Codes |
Capsular Contracture (1761); Impaired Healing (2378)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A review of the device history record has been completed.No deviations or non-conformances noted.The events of "capsular contracture¿ and "delayed healing" are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: "capsular contracture,¿ baker grade not specified, ¿scabbing and delayed healing,¿ ¿increased risk of bia-alcl,¿ ¿anguish and anxiety,¿ ¿bilateral tightness¿ and ¿mental pain.¿.
|
| |
|
Event or Problem Description
|
|
Patient representative reported patient experienced ¿capsular contracture,¿ baker grade not specified, ¿scabbing and delayed healing,¿ ¿increased risk of bia-alcl,¿ ¿anguish and anxiety,¿ ¿bilateral tightness¿ and ¿mental pain.¿ patient representative also reported patient experienced ¿suffering,¿ ¿disfigurement¿ and ¿suffered personal injuries and related damages;¿ these events are not related to the device.Device was explanted.This record is for the left side.
|
| |
|
Event or Problem Description
|
|
Patient representative reported patient experienced ¿capsular contracture,¿ baker grade not specified, ¿scabbing and delayed healing,¿ ¿increased risk of bia-alcl,¿ ¿anguish and anxiety,¿ ¿bilateral tightness¿ and ¿mental pain.¿ patient representative also reported patient experienced ¿suffering,¿ ¿disfigurement¿ and ¿suffered personal injuries and related damages;¿ these events are not related to the device.Device was explanted.This record is for the left side.
|
| |
|
Additional Manufacturer Narrative
|
|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.
|
| |
|
Search Alerts/Recalls
|